Securitas AB to publish the Full-Year Report January-December 2025 on February 4, 2026
STOCKHOLM, Jan. 27, 2026 /PRNewswire/ — Securitas AB will publish the Full-Year Report January-December 2025 on Wednesday February 4, 2026, at 8.00 a.m. (CET).... Read more.
Alrajhi Medicine to Digitize its Healthcare Operations with Oracle to Foster Better Patient and Staff Experiences
Adopts Oracle Health Foundation EHR and Oracle Fusion Cloud Applications to increase efficiency and drive growth AUSTIN, Texas, Jan. 27, 2026 /PRNewswire/ —... Read more.
Current geopolitical tensions are putting pressure on the internal security of European organisations
84% of European high-risk profile organisations do not feel well equipped to detect and handle insider incidents, according to the Insider Risk Trend Report 2026... Read more.
EPG Completes Nearly US$100 Million Series B Financing, Bolsters Global Data Center Delivery Capabilities
SINGAPORE, Jan. 27, 2026 /PRNewswire/ — EPG recently completed its Series B financing, raising nearly US$100 million. The round was co-led by international... Read more.
Maveric Systems Recognised as a Major Contender in Everest Group PEAK Matrix® 2025 Assessments
DUBAI, UAE, Jan. 27, 2026 /PRNewswire/ — Maveric Systems, a niche banking and financial services technology specialist, announced that it has been recognised... Read more.
Multiverse to deliver AI skills to 100,000 German workers through acquisition of StackFuel
Berlin HQ’d data and AI upskilling provider becomes part of Multiverse, Europe’s only EdTech unicorn Terms see substantial investment into StackFuel’s... Read more.
Libevitug Approved in China as First-in-Class Treatment for Hepatitis D
BEIJING, Jan. 27, 2026 /PRNewswire/ — Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval... Read more.
INTURAI VENTURES AND TALIUS SIGN LOI FOR ROLLOUT OF AI-POWERED SENSING AND SPATIAL INTELLIGENCE TECHNOLOGY
(CSE: URAI / OTC: URAIF / FSE: 3QG0) [email protected] Highlights Inturai advances its engagement with Talius following sustained collaboration Targeting USD... Read more.
Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030
Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. Growth over the financial year was driven by increased sales in oncology, particularly... Read more.
Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
Improved Pharma announces the publication of its research detailing the crystal structure of Ritonavir Form IV in Crystal Growth & Design. Using micro-electron... Read more.